The present invention relates to mononucleoside phosphate compounds that have the benefits of a dinucleotide pharmaceutical. These mononucleoside phosphates can be made from a mononucleotide that has been modified by attaching a degradation resistant substituent on the terminal phosphate of a polyphosphate mononucleotide. By attaching this degradation resistant substituent, the stability from degradation matches or exceeds those of certain dinucleotides.

 
Web www.patentalert.com

< Antigen associated with type 1 Diabetes Mellitus

< Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof

> Methods for treating a breach or puncture in a blood vessel

> Selected nucleotide sequences isolated from pathogenic strains of Haemophilus influenzae
~ 00292